Verdence Capital Advisors LLC Edwards Lifesciences Corp Transaction History

Verdence Capital Advisors LLC

$1.1 Billion
Q2 2024

A detailed history of Verdence Capital Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 10,925 shares of EW stock, worth $715,369. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,925

Previous 11,599 5.81%

Holding current value

$715,369

Previous $1.11 Million 8.94%

% of portfolio

0.09%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$84.3 - $94.31 $56,818 - $63,564	-674 Reduced 5.81%	10,925 $1.01 Million
Q1 2024 Apr 25, 2024	BUY	$72.54 - $95.56 $55,783 - $73,485	769 Added 7.1%	11,599 $1.11 Million
Q4 2023 Jan 31, 2024	BUY	$61.71 - $77.76 $93,120 - $117,339	1,509 Added 16.19%	10,830 $825,000
Q3 2023 Oct 25, 2023	BUY	$69.28 - $93.38 $90,271 - $121,674	1,303 Added 16.25%	9,321 $645,000
Q2 2023 Jul 28, 2023	BUY	$81.41 - $94.33 $652,745 - $756,337	8,018 New	8,018 $756,000
Q4 2022 Jan 20, 2023	BUY	$68.3 - $87.44 $244,855 - $313,472	3,585 Added 68.04%	8,854 $0
Q3 2022 Nov 15, 2022	BUY	$82.37 - $107.29 $82 - $107	1 Added 0.02%	5,269 $435,000
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $7,093 - $10,518	-82 Reduced 1.53%	5,268 $501,000
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $28,446 - $35,806	279 Added 5.5%	5,350 $630,000
Q4 2021 Jan 26, 2022	SELL	$106.37 - $130.68 $5,318 - $6,534	-50 Reduced 0.98%	5,071 $657,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $28,300 - $33,756	275 Added 5.67%	5,121 $580,000
Q2 2021 Aug 06, 2021	SELL	$83.84 - $104.76 $18,109 - $22,628	-216 Reduced 4.27%	4,846 $502,000
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $3,383 - $3,898	-43 Reduced 0.84%	5,062 $423,000
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $286 - $364	4 Added 0.08%	5,105 $466,000
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $3,628 - $4,721	54 Added 1.07%	5,101 $407,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $193,794 - $259,167	3,368 Added 200.6%	5,047 $349,000
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $4,087 - $6,318	-78 Reduced 4.44%	1,679 $317,000
Q4 2019 Feb 03, 2020	SELL	$71.7 - $82.09 $1,075 - $1,231	-15 Reduced 0.85%	1,757 $410,000
Q3 2019 Mar 06, 2020	SELL	$61.55 - $75.43 $14,094 - $17,273	-229 Reduced 11.44%	1,772 $390,000
Q1 2019 Mar 02, 2020	BUY	$47.89 - $64.05 $21,885 - $29,270	457 Added 29.6%	2,001 $383,000
Q4 2018 Feb 25, 2020	SELL	$46.41 - $56.94 $3,016 - $3,701	-65 Reduced 4.04%	1,544 $236,000
Q3 2018 Feb 25, 2020	BUY	$45.7 - $58.03 $7,631 - $9,691	167 Added 11.58%	1,609 $280,000
Q2 2018 Feb 11, 2020	SELL	$42.45 - $51.3 $424 - $513	-10 Reduced 0.69%	1,442 $210,000
Q1 2018 Jan 30, 2020	BUY	$37.19 - $47.45 $53,999 - $68,897	1,452 New	1,452 $203,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Edwards Lifesciences Corp Transaction History